Ardent Health (ARDT) CEO granted 134,615 shares, withholds 18,978 for taxes

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Ardent Health, Inc. President and CEO Martin Bonick reported compensation-related stock activity involving restricted stock units and associated tax withholding.

On April 1, 2026, he received 134,615 shares of common stock as a grant or award. These restricted stock units vest in three substantially equal installments on each anniversary of April 1, 2026, subject to his continued service with the company.

To cover tax obligations upon vesting of restricted stock units under Rule 16b-3, 10,952 shares were withheld at a reference price of $8.67 per share on April 1, 2026 and 8,026 shares were withheld at $8.56 per share on March 31, 2026. Following these transactions, Bonick directly owned 1,437,937 shares of Ardent Health common stock.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Bonick Martin

Role President and CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	10,952	$8.67	$95K
Grant/Award	Common Stock	134,615	$0.00	--
Tax Withholding	Common Stock	8,026	$8.56	$69K

Holdings After Transaction: Common Stock — 1,303,322 shares (Direct)

Footnotes (1)

Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Represents the closing price of the common stock of the Issuer on March 31, 2026. Represents the closing price of the common stock of the Issuer on April 1, 2026. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Key Figures

RSU grant: 134,615 shares Tax-withholding shares: 18,978 shares Withholding batch 1: 8,026 shares at $8.56 +2 more

5 metrics

RSU grant 134,615 shares Common stock award to CEO on April 1, 2026

Tax-withholding shares 18,978 shares Total shares withheld for RSU tax payments

Withholding batch 1 8,026 shares at $8.56 Closing price on March 31, 2026

Withholding batch 2 10,952 shares at $8.67 Closing price on April 1, 2026

Shares owned after 1,437,937 shares CEO’s direct Ardent Health holdings after transactions

Key Terms

restricted stock units, Rule 16b-3, grant, award, or other acquisition, tax-withholding disposition, +1 more

5 terms

restricted stock units financial

"Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 16b-3 regulatory

"Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3."

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

vesting financial

"restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 04:24 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bonick Martin

(Last)

(First)

(Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD

TENNESSEE

37027

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/31/2026		F		8,026⁽¹⁾	D	$8.56⁽²⁾	1,314,274	D
Common Stock	04/01/2026		F		10,952⁽¹⁾	D	$8.67⁽³⁾	1,303,322	D
Common Stock	04/01/2026		A		134,615⁽⁴⁾	A	$0	1,437,937	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

2. Represents the closing price of the common stock of the Issuer on March 31, 2026.

3. Represents the closing price of the common stock of the Issuer on April 1, 2026.

4. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider stock transactions did Ardent Health (ARDT) CEO Martin Bonick report?

Martin Bonick reported a grant of 134,615 Ardent Health common shares and two tax-related share withholdings totaling 18,978 shares. These events relate to restricted stock units vesting and associated tax payments, rather than open-market buying or selling of stock.

How many Ardent Health (ARDT) shares were granted to CEO Martin Bonick?

Martin Bonick was granted 134,615 shares of Ardent Health common stock. The award consists of restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to his continued service with the company.

Why were Ardent Health (ARDT) shares withheld from Martin Bonick?

Shares were withheld to pay taxes due upon vesting of restricted stock units, in accordance with Rule 16b-3. Specifically, 10,952 shares and 8,026 shares of Ardent Health common stock were withheld on March 31 and April 1, 2026, respectively, instead of a cash tax payment.

At what prices were the Ardent Health (ARDT) tax-withholding shares valued?

The withheld shares were valued using closing stock prices: 8,026 shares at $8.56 on March 31, 2026, and 10,952 shares at $8.67 on April 1, 2026. These prices were cited as the issuer’s common stock closing prices on those dates.

How many Ardent Health (ARDT) shares does CEO Martin Bonick own after these transactions?

After the reported Form 4 transactions, Martin Bonick directly owned 1,437,937 shares of Ardent Health common stock. This figure reflects the grant of restricted stock units and the share withholdings for tax obligations disclosed in the filing.

How do Martin Bonick’s Ardent Health (ARDT) restricted stock units vest?

The restricted stock units granted to Martin Bonick vest in three substantially equal installments. Vesting occurs on each anniversary of April 1, 2026, and is conditioned on his continued service with Ardent Health through each applicable vesting date.